Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETRA
ISRCTN16993990Phase 4Active, not recruiting
- Sponsor
- University College London
- Start
- Aug 2023
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Pregabalin adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoint: Anxiety symptoms at 12 weeks. Started Aug 2023; status: active, not recruiting.
02
Drugs
pregabalin
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on ISRCTN16993990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16993990.